SCHONEFELD
Germany
5
2019-12-05
5
2022-11-22
These are the the leading inventors for applications assigned to ADVERIO PHARMA GMBH:
ADVERIO PHARMA GMBH based in SCHONEFELD, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Method of identifying a subgroup of patients suffering from dcSSc which benefits from a treatment with sGC stimulators and sGC activators in a higher degree than a control group
#2 | 2017-09-28 ✅ Patent 9,993,476 granted on 2018-06-12Substituted 5-flouro-1H-pyrazolopyridines and their use
#3 | 2016-01-14 ✅ Patent 9,604,948 granted on 2017-03-28Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
#4 | 2014-09-25 ✅ Patent 10,030,014 granted on 2018-07-24Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
#5 | 2014-02-06 ✅ Patent 10,189,856 granted on 2019-01-29Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)
Also check out ADVERIO PHARMA GMBH's (Schonefeld, Germany) applicant profile with 1 patent applications submitted.
169201 ⎘